
Opinion|Videos|January 31, 2025
Overcoming Logistical Hurdles in Bispecific Therapy Implementation
Panelists discuss the most common logistical challenges encountered when implementing bispecific therapies in both academic and community settings.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What are the most common logistical challenges you encounter when implementing bispecific therapies in both academic and community settings? (Dr Allan)
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Inebilizumab for Generalized Myasthenia Gravis
2
Clascoterone 5% Delivers Strong Phase 3 Results for Androgenetic Alopecia
3
Cardiotoxicity Remains a Concern as Breast Cancer Survival Rates Improve: Eric H. Yang, MD
4
5 Key Oncology FDA Approvals From November
5








































